Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
99.4M
-
Number of holders
-
222
-
Total shares
-
45.5M
-
Shares change
-
-223K
-
Total reported value, excl. options
-
$3.63B
-
Value change
-
-$39M
-
Put/Call ratio
-
1.05
-
Number of buys
-
100
-
Number of sells
-
-108
-
Price
-
$79.69
Significant Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q4 2021
229 filings reported holding BEAM - Beam Therapeutics Inc. - COMMON STOCK as of Q4 2021.
Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.5M shares
of 99.4M outstanding shares and own 45.8% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (7.98M shares), VANGUARD GROUP INC (4.7M shares), BlackRock Inc. (4.06M shares), FMR LLC (3.92M shares), Temasek Holdings (Private) Ltd (3.46M shares), MWG Management Ltd. (2.35M shares), FARALLON CAPITAL MANAGEMENT LLC (2.27M shares), Redmile Group, LLC (1.89M shares), STATE STREET CORP (1.68M shares), and GOLDMAN SACHS GROUP INC (974K shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.